News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) Gains on Report Touting Experimental Cancer Drugs


8/20/2012 7:33:39 AM

Geron Corp. (GERN), a Menlo Park, California-based biotechnology company, gained the the most in almost two months after a report on the website Seeking Alpha touted the company’s cancer drugs under development.

Geron rose 15 percent to $1.97 at 2:06 p.m. New York time in its biggest intraday advance since June 22. The shares (GERN) lost 38 percent over the last 12 months through yesterday.

Read at Seeking Alpha
Read at BusinessWeek

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES